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We read with great interest the recent article by Kashima et al,1 in which the authors 
report a case of asymmetric severity of diabetic retinopathy in Waardenburg   syndrome. 
We want to highlight some concerns regarding this report. Previous reports have 
described many systemic and local factors associated with the development of asym-
metric diabetic retinopathy.2,3 These include myopia $5 D, anisometropia .1 D, 
amblyopia, unilateral elevated intraocular pressure, complete posterior vitreous detach-
ment, unilateral carotid artery stenosis, ocular ischemic syndrome, and chorioretinal 
scarring.2,3 In any suspected case of asymmetric diabetic retinopathy, it is prudent to 
rule out the abovementioned factors first. In the present case, although the authors 
clearly mention the absence of internal carotid and ophthalmic artery obstruction on 
magnetic resonance angiography, it would have been more informative if the authors 
had also provided the refractive error, intraocular pressure, and posterior vitreous 
detachment status of both the eyes.
Likewise, it would have been useful to note the arm-retina time and retinal arterio-
venous filling time in both the eyes on fundus fluorescein angiography, which is usually 
used to diagnose ocular ischemic syndrome by monitoring extension of the retinal 
circulation time, including time of blood circulation from the arm to the retina and the 
retinal arteriovenous filling time.4,5 The mere absence of internal carotid obstruction 
on magnetic resonance angiography cannot rule out the presence of ocular ischemic 
syndrome because, rarely, ocular ischemic syndrome can also occur secondary to other 
causes, such as arteritis.6,7 Comparing the arm-retina time and retinal arteriovenous 
filling time on fundus fluorescein angiography in both the eyes would be more helpful 
to rule out ocular ischemic syndrome.
Kashima et al report the presence of more advanced diabetic retinopathy in the 
eye with sectoral iris hypochromia than the eye in which iris hypochromia was total.1 
Presence of asymmetric diabetic retinopathy in association with iris heterochromia 
has been reported earlier in Fuchs’ heterochromic cyclitis, in which the affected 
eye (hypochromic iris) had nonproliferative diabetic retinopathy and the fellow eye 
had peripheral diabetic retinopathy.8 Although the authors hypothesized that Fuchs’ 
heterochromic cyclitis protected the affected eye from progression to peripheral 
diabetic retinopathy, they could not find a clear mechanism for the same.8 The cases 
reported by Kashima et al1 and Murray et al8 bear similarities, and may suggest 
a common link in understanding the pathogenesis behind asymmetric severity of 
diabetic retinopathy.
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Further, asymmetric diabetic retinopathy has been defined 
as proliferative diabetic retinopathy in one eye and nonprolif-
erative diabetic retinopathy or no retinopathy in the fellow eye, 
persisting for at least two years.2 Duker et al defined it as the 
presence of proliferative diabetic retinopathy with high-risk 
characteristics in one eye, with neither proliferative nor pre-
proliferative changes in the opposite eye.9 Other authors have 
also defined asymmetric diabetic retinopathy as proliferative 
diabetic retinopathy in one eye and nonproliferative diabetic 
retinopathy in the other eye.10 In the present case, the patient 
had proliferative diabetic retinopathy in both eyes with the 
presence of a huge neovascularization in the right eye and a 
tiny neovascularization in the left eye. Use of the term “asym-
metric diabetic retinopathy” in this patient, as the authors have 
done in the discussion section, may not be correct using any 
definition of asymmetric diabetic retinopathy.   Asymmetric 
diabetic retinopathy is a rare disease. We conducted a 
population-based study in south India (  SN-DREAMS 1), 
in which 1414 subjects with type 2 diabetes were analyzed 
for the presence of diabetic retinopathy.11 Of 1414 subjects, 
diabetic retinopathy was present in 255 (18%), and asym-
metric diabetic retinopathy2 in only two (0.14%).
In addition, the authors speculate that hypopigmentation 
of the fundus in Waardenburg syndrome may be responsible 
for the reduction in retinal metabolism, which led to a reduc-
tion in oxygen consumption and prevented further aggrava-
tion of diabetic retinopathy, as occurs in retinitis pigmentosa.1 
It is known that hypopigmentary changes in the retina protect 
against diabetic retinopathy, but Smith et al reported the 
presence of diabetic retinopathy in a patient with loss of 
retinal pigmentation and speculated that the retinal dystrophy 
associated with A3243G does not prevent the development 
of diabetic retinopathy.12 Hence, there might be other mecha-
nisms involved in the varied severity of diabetic retinopathy 
in subjects with hypopigmented fundi. Genetic analysis of 
such cases might bring more insight regarding this.
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Thank you for providing the opportunity to show more 
detailed data on this issue. The myopia in both of the patient’s 
eyes was the same at −4.5 D. Astigmatism was −1.75 D in the 
right eye and −0.5 D in the left eye. The intraocular pressure in 
both eyes was 13 mmHg, measured by noncontact tonometer, 
respectively. There was no posterior vitreous detachment seen 
in either eye, and we are sure that the authors suspected no 
posterior vitreous detachment because no neovascularization 
developed in either eye in this patient. The clinical condition 
was almost the same in both eyes.
As the authors of this letter stated, comparing both 
eyes for arm-retina time and retinal arteriovenous filling 
time on fundus fluorescein angiography may be helpful. 
Actually, the filling time of the right eye was normal 
(20.4 seconds). However, measuring these times in both 
eyes is not an easy task in most clinics because the patient 
must visit the clinic twice only, just for these measure-
ments, which is unacceptable from the points of view of 
money and time. In addition, the systemic condition of 
patients with diabetes is usually not good for angiography, 
so we think the comments of these authors are clinically   
inappropriate.
The authors of this letter also said that Duker defined 
this condition as the presence of peripheral diabetic retin-
opathy with high-risk characteristics in one eye, with neither 
proliferative nor preproliferative changes in the opposite eye. 
However, Duker et al9 when defining it for their study, never 
proposed a definition of asymmetric peripheral diabetic retin-
opathy. In our case, clearly the width of neovascularization in 
both fundi were different, which was proven by fluorescein 
angiography.
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